Mutations in a gene encoding a midbody protein in binucleated Reed-Sternberg cells of Hodgkin lymphoma

Cell Cycle

Volumn 9, Issue 4, 2010, Pages 670-675

  Krem, Maxwell M ^a   Salipante, Stephen J ^a   Horwitz, Marshall S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

BARD1; BRCA1; BRCA2; Cytokinesis; Hodgkin lymphoma; Keap1; Kelch; KLHDC8B; Midbody

Indexed keywords

AURORA B KINASE; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; BRCA2 PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; TRANSCRIPTION FACTOR NRF2; BARD1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; KLHDC8B PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

CELL CYCLE S PHASE; CHROMOSOME 3P; CHROMOSOME ANALYSIS; CLASSICAL HODGKIN LYMPHOMA; CLINICAL TRIAL; CYTOKINESIS; GENE MUTATION; GENETIC CODE; GENETIC MARKER; HELA CELL; HUMAN; IMMUNOFLUORESCENCE TEST; INTERNAL RIBOSOME ENTRY SITE; KLHDC8 GENE; MOLECULAR CLONING; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REED STERNBERG CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR GENE; TUMOR SUPPRESSOR GENE; UBIQUITINATION; ARTICLE; CHEMISTRY; GENETICS; HODGKIN DISEASE; METABOLISM; MUTATION;

BRCA1 PROTEIN; BRCA2 PROTEIN; CELL CYCLE PROTEINS; CYTOKINESIS; HELA CELLS; HODGKIN DISEASE; HUMANS; MUTATION; REED-STERNBERG CELLS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 77953154154     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.4.10780     Document Type: Review

References (65)

1. Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer 2009; 9:23-6.
2. Kutok JL, Wang F. Spectrum of Epstein-Barr virusassociated diseases. Annu Rev Pathol 2006; 1:375-404.
3. Altieri A, Hemminki K. The familial risk of Hodgkin's lymphoma ranks among the highest in the Swedish Family-Cancer Database. Leukemia 2006; 20:2062-3.
4. Diepstra A, Niens M, te Meerman GJ, Poppema S, van den Berg A. Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region. Eur J Haematol Suppl 2005; 34-41.
5. Coutinho A, Carneiro-Sampaio M. Primary immunodeficiencies unravel critical aspects of the pathophysiology of autoimmunity and of the genetics of autoimmune disease. J Clin Immunol 2008; 28:4-10.
6. Salipante SJ, Mealiffe ME, Wechsler J, Krem MM, Liu Y, Namkoong S, et al. Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells. Proc Natl Acad Sci USA 2009; 106:14920-5.
7. Szeles A. Fluorescence in situ hybridization (FISH) in the molecular cytogenetics of cancer. Acta Microbiol Immunol Hung 2002; 49:69-80.
8. Yang Q, Yoshimura G, Mori I, Sakurai T, Kakudo K. Chromosome 3p and breast cancer. J Hum Genet 2002; 47:453-9.
9. Hesson LB, Cooper WN, Latif F. Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene 2007; 26:7283-301.
10. Landgren O, Pfeiffer RM, Stewart L, Gridley G, Mellemkjaer L, Hemminki K, et al. Risk of second malignant neoplasms among lymphoma patients with a family history of cancer. Int J Cancer 2007; 120:1099-102.
11. Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, Li XL, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 2004; 64:1972-4.
12. Chan AS, To KF, Lo KW, Mak KF, Pak W, Chiu B, et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from Southern Chinese. Cancer Res 2000; 60:5365-70.
13. Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI, et al. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci USA 1998; 95:3042-7.
14. Prag S, Adams JC. Molecular phylogeny of the kelch-repeat superfamily reveals an expansion of BTB/kelch proteins in animals. BMC Bioinformatics 2003; 4:42.
15. Adams J, Kelso R, Cooley L. The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol 2000; 10:17-24.
16. Xue F, Cooley L. kelch encodes a component of intercellular bridges in Drosophila egg chambers. Cell 1993; 72:681-93.
17. Ito N, Phillips SE, Stevens C, Ogel ZB, McPherson MJ, Keen JN, et al. Novel thioether bond revealed by a 1.7 A crystal structure of galactose oxidase. Nature 1991; 350:87-90.
18. Eswar N, Eramian D, Webb B, Shen MY, Sali A. Protein structure modeling with MODELLER. Methods Mol Biol 2008; 426:145-59.
19. Luckey CJ, Bhattacharya D, Goldrath AW, Weissman IL, Benoist C, Mathis D. Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc Natl Acad Sci USA 2006; 103:3304-9.
20. Otegui MS, Verbrugghe KJ, Skop AR. Midbodies and phragmoplasts: analogous structures involved in cytokinesis. Trends Cell Biol 2005; 15:404-13.
21. Schepens B, Tinton SA, Bruynooghe Y, Parthoens E, Haegman M, Beyaert R, et al. A role for hnRNP C1/ C2 and Unr in internal initiation of translation during mitosis. EMBO J 2007; 26:158-69.
22. Wilker EW, van Vugt MA, Artim SA, Huang PH, Petersen CP, Reinhardt HC, et al. 14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature 2007; 446:329-32.
23. Kadin ME, Asbury AK. Long term cultures of Hodgkin's tissue. A morphologic and radioautographic study. Lab Invest 1973; 28:181-4.
24. Drexler HG, Gignac SM, Hoffbrand AV, Minowada J. Formation of multinucleated cells in a Hodgkin's-disease-derived cell line. Int J Cancer 1989; 43:1083-90.
25. Leoncini L, Spina D, Megha T, Gallorini M, Tosi P, Hummel M, et al. Cell kinetics, morphology and molecular IgVH gene rearrangements in Hodgkin's disease. Leuk Lymphoma 1997; 26:307-16.
26. Kuppers R, Brauninger A, Muschen M, Distler V, Hansmann ML, Rajewsky K. Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusions. Blood 2001; 97:818-21.
27. Barrios L, Caballin MR, Miro R, Fuster C, Berrozpe G, Subias A, et al. Chromosome abnormalities in peripheral blood lymphocytes from untreated Hodgkin's patients. A possible evidence for chromosome instability. Hum Genet 1988; 78:320-4.
28. M'Kacher R, Girinsky T, Koscielny S, Dossou J, Violot D, Beron-Gaillard N, et al. Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients. Int J Radiat Oncol Biol Phys 2003; 57:321-6.
29. Falzetti D, Crescenzi B, Matteuci C, Falini B, Martelli MF, Van Den Berghe H, et al. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease. Haematologica 1999; 84:298-305.
30. Watanabe A, Inokuchi K, Yamaguchi H, Mizuki T, Tanosaki S, Shimada T, et al. Near-triploidy and near-tetraploidy in hematological malignancies and mutation of the p53 gene. Clin Lab Haematol 2004; 26:25-30.
31. Hemminki K, Li X. Cancer risks in twins: results from the Swedish family-cancer database. Int J Cancer 2002; 99:873-8.
32. Timms AE, Horwitz MS. KLHDC8B in Hodgkin lymphoma and possibly twinning. Commun Integr Biol In press.
33. Chang F, Feierbach B, Martin S. Regulation of actin assembly by microtubules in fission yeast cell polarity. Novartis Found Symp 2005; 269:59-66.
34. Knaus M, Cameroni E, Pedruzzi I, Tatchell K, De Virgilio C, Peter M. The Bud14p-Glc7p complex functions as a cortical regulator of dynein in budding yeast. EMBO J 2005; 24:3000-11.
35. Sasagawa K, Matsudo Y, Kang M, Fujimura L, Iitsuka Y, Okada S, et al. Identification of Nd1, a novel murine kelch family protein, involved in stabilization of actin filaments. J Biol Chem 2002; 277:44140-6.
36. Skop AR, Liu H, Yates J, 3rd, Meyer BJ, Heald R. Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms. Science 2004; 305:61-6.
37. Sumara I, Quadroni M, Frei C, Olma MH, Sumara G, Ricci R, Peter M. A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes, regulating mitotic progression and completion of cytokinesis in human cells. Dev Cell 2007; 12:887-900.
38. Glotzer M. The molecular requirements for cytokinesis. Science 2005; 307:1735-9.
39. Zhu C, Bossy-Wetzel E, Jiang W. Recruitment of MKLP1 to the spindle midzone/midbody by INCENP is essential for midbody formation and completion of cytokinesis in human cells. Biochem J 2005; 389:373-81.
40. Matuliene J, Kuriyama R. Role of the midbody matrix in cytokinesis: RNAi and genetic rescue analysis of the mammalian motor protein CHO1. Mol Biol Cell 2004; 15:3083-94.
41. Lehtonen S, Shah M, Nielsen R, Iino N, Ryan JJ, Zhou H, et al. The Endocytic Adaptor Protein ARH Associates with Motor and Centrosomal Proteins and Is Involved in Centrosome Assembly and Cytokinesis. Mol Biol Cell 2008; 19:2949-61.
42. Durcan TM, Halpin ES, Rao T, Collins NS, Tribble EK, Hornick JE, et al. Tektin 2 is required for central spindle microtubule organization and the completion of cytokinesis. J Cell Biol 2008; 181:595-603.
43. Daniels MJ, Wang Y, Lee M, Venkitaraman AR. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 2004; 306:876-9.
44. Low SH, Li X, Miura M, Kudo N, Quinones B, Weimbs T. Syntaxin 2 and endobrevin are required for the terminal step of cytokinesis in mammalian cells. Dev Cell 2003; 4:753-9.
45. Cutts SM, Fowler KJ, Kile BT, Hii LL, O'Dowd RA, Hudson DF, et al. Defective chromosome segregation, microtubule bundling and nuclear bridging in inner centromere protein gene (Incenp)-disrupted mice. Hum Mol Genet 1999; 8:1145-55.
46. Kinoshita M, Kumar S, Mizoguchi A, Ide C, Kinoshita A, Haraguchi T, et al. Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures. Genes Dev 1997; 11:1535-47.
47. Terada Y, Tatsuka M, Suzuki F, Yasuda Y, Fujita S, Otsu M. AIM-1: a mammalian midbody-associated protein required for cytokinesis. EMBO J 1998; 17:667-76.
48. Pohl C, Jentsch S. Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. Cell 2008; 132:832-45.
49. Hayes JD, McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 2009; 34:176-88.
50. Kensler TW, Wakabayashi N. Nrf2: Friend or Foe for Chemoprevention? Carcinogenesis 2009.
51. Lee DF, Kuo HP, Liu M, Chou CK, Xia W, Du Y, et al. KEAP1 E3 ligase-mediated downregulation of NFkappaB signaling by targeting IKKbeta. Mol Cell 2009; 36:131-40.
52. Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 2008; 124:31-42.
53. Irminger-Finger I, Jefford CE. Is there more to BARD1 than BRCA1? Nat Rev Cancer 2006; 6:382-91.
54. Greenberg RA. Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network. Chromosoma 2008; 117:305-17.
55. Ashworth A. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. J Clin Oncol 2008; 26:3785-90.
56. Lotti LV, Ottini L, D'Amico C, Gradini R, Cama A, Belleudi F, et al. Subcellular localization of the BRCA1 gene product in mitotic cells. Genes Chromosomes Cancer 2002; 35:193-203.
57. Ryser S, Dizin E, Jefford CE, Delaval B, Gagos S, Christodoulidou A, et al. Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2. Cancer Res 2009; 69:1125-34.
58. Jonsdottir AB, Vreeswijk MP, Wolterbeek R, Devilee P, Tanke HJ, Eyfjord JE, et al. BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts. Cell Oncol 2009; 31:191-201.
59. Hanks S, Coleman K, Reid S, Plaja A, Firth H, Fitzpatrick D, et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 2004; 36:1159-61.
60. Matsuura S, Matsumoto Y, Morishima K, Izumi H, Matsumoto H, Ito E, et al. Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome. Am J Med Genet A 2006; 140:358-67.
61. Rai R, Phadnis A, Haralkar S, Badwe RA, Dai H, Li K, et al. Differential regulation of centrosome integrity by DNA damage response proteins. Cell Cycle 2008; 7:2225-33. (Pubitemid 352031525)
62. Saskova A, Solc P, Baran V, Kubelka M, Schultz RM, Motlik J. Aurora kinase A controls meiosis I progression in mouse oocytes. Cell Cycle 2008; 7:2368-76.
63. Martin-Subero JI, Knippschild U, Harder L, Barth TF, Riemke J, Grohmann S, et al. Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma? Leukemia 2003; 17:2214-9.
64. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009; 460:278-82.
65. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321:1801-6.